NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Radiologie, published by SPRINGER HEIDELBERG, is an emerging journal dedicated to the fields of radiology, nuclear medicine, and imaging. With an ISSN of 2731-7048 and E-ISSN 2731-7056, this journal does not currently offer open access, providing a traditional yet respected platform for scholarly communication. Founded in 2022, it aims to advance the understanding of cutting-edge imaging techniques and their applications in clinical practice, contributing to improvements in diagnostic accuracy and patient care. Despite its recent establishment, Radiologie is positioned within the Q4 quartile category, reflecting its developing presence in the academic landscape, with a current Scopus rank of #231 out of 333 in its category. The journal serves as a vital resource for researchers, professionals, and students seeking to stay abreast of the latest developments in radiological science, imaging technology, and their clinical implications, ensuring ongoing engagement and advancement in this critical area of healthcare.

Radiologia Medica, published by Springer-Verlag Italia SRL, is a premier Italian journal dedicated to the field of radiology, nuclear medicine, and imaging. With a rich history dating back to 1947, this journal has consistently provided cutting-edge research and findings, contributing significantly to advancements in medical imaging techniques and practices. As evidenced by its impressive Q1 rankings in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine and Imaging, Radiologia Medica holds a prestigious position within the top tier of medical journals, ranked #11 out of 333 in its category and residing in the 96th percentile according to Scopus metrics. Although it is not currently offered as an Open Access journal, its robust subscription model supports extensive research dissemination. Researchers, professionals, and students alike will find invaluable insights and knowledge critical for advancing their understanding and practice within this dynamic field. Situated in Milan, Italy, Radiologia Medica continues to be an influential platform for the exchange of high-quality research, bridging various disciplines and promoting excellence in radiological science.

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.